Comparison of Cone-Beam Tomography and Cross-Sectional Imaging for Volumetric and Dosimetric Calculations in Resin Yttrium-90 Radioembolization

被引:17
作者
Ertreo, Marco [1 ]
Choi, Hailey [1 ]
Field, David [1 ]
Lischalk, Jonathan W. [2 ]
Cohen, Emil [1 ]
Lynskey, George E. [1 ]
Caridi, Theresa [1 ]
Buckley, Donna [1 ]
Unger, Keith [2 ]
Kim, Alexander Y. [1 ]
机构
[1] Medstar Georgetown Univ Hosp, Dept Radiol, Div Intervent Radiol, 3800 Reservoir Rd NW, Washington, DC 20007 USA
[2] Medstar Georgetown Univ Hosp, Dept Radiat Oncol, 3800 Reservoir Rd NW, Washington, DC 20007 USA
关键词
Cone-beam CT; CBCT; Y90; Radioembolization; Dosimetry; HEPATOCELLULAR-CARCINOMA; LIVER-DISEASE; CT; TUMOR; GUIDANCE; IMPACT;
D O I
10.1007/s00270-018-2030-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PurposeTo compare the use of cone-beam computed tomography versus contrast-enhanced computed tomography (CT) and magnetic resonance imaging (MRI) in the calculation of liver volume and planned dose for yttrium-90 radioembolization.Materials and MethodsThe study retrospectively assessed 47 consecutive patients who underwent resin Y-90 radioembolization consecutively over a 2-year period at a single center. Volume calculation software was used to determine perfused lobar liver volumes from cone-beam CT (CBCT) images obtained during mapping angiography. CBCT-derived volumes were compared with perfused lobar volume derived from contrast-enhanced CT and MRI. Nominal activities as determined by the SIR-Spheres Microspheres Activity Calculator were similarly calculated and compared using both CBCT and conventionally acquired volumes.ResultsA total of 82 hepatic lobes were assessed in 47 patients. The mean percentage difference between combined CT-MRI- and CBCT-derived calculated lobar volumes was 25.3% (p=0.994). The mean percentage difference in calculated dose between the two methods was 21.824.6% (p=0.42). Combined left and right lobar CT-derived dose difference was less than 10% in 22 lobes, between 10 and 25% in 20 lobes, between 25 and 50% in 13 lobes and greater than 50% in 5 lobes. Combined left and right lobar MRI-derived dose difference was less than 10% in 11 lobes, between 10 and 25% in 7 lobes, between 25 and 50% in 2 lobes and greater than 50% in 1 lobe.Conclusions Although volume measurements derived from CT/MRI did not differ significantly from those derived from CBCT, variability between the two methods led to large and unexpected differences in calculated dose.
引用
收藏
页码:1857 / 1866
页数:10
相关论文
共 22 条
  • [1] [Anonymous], SIR SPHER MICR ACT C
  • [2] Radioembolization-induced liver disease: a systematic review
    Braat, Manon N. G. J. A.
    van Erpecum, Karel J.
    Zonnenberg, Bernard A.
    van den Bosch, Maurice A. J.
    Lam, Marnix G. E. H.
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 29 (02) : 144 - 152
  • [3] Hepatic arterioportal shunts: Dynamic CT and MR features
    Choi, BI
    Lee, KH
    Han, JK
    Lee, JM
    [J]. KOREAN JOURNAL OF RADIOLOGY, 2002, 3 (01) : 1 - 15
  • [4] PET/MRI of Hepatic 90Y Microsphere Deposition Determines Individual Tumor Response
    Fowler, Kathryn J.
    Maughan, Nichole M.
    Laforest, Richard
    Saad, Nael E.
    Sharma, Akash
    Olsen, Jeffrey
    Speirs, Christina K.
    Parikh, Parag J.
    [J]. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2016, 39 (06) : 855 - 864
  • [5] Dosimetry Based on 99mTc-Macroaggregated Albumin SPECT/CT Accurately Predicts Tumor Response and Survival in Hepatocellular Carcinoma Patients Treated with 90Y-Loaded Glass Microspheres: Preliminary Results
    Garin, Etienne
    Lenoir, Laurence
    Rolland, Yan
    Edeline, Julien
    Mesbah, Habiba
    Laffont, Sophie
    Poree, Philippe
    Clement, Bruno
    Raoul, Jean-Luc
    Boucher, E.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2012, 53 (02) : 255 - 263
  • [6] Prognostic factors and prevention of radioembolization-induced liver disease
    Gil-Alzugaray, Belen
    Chopitea, Ana
    Inarrairaegui, Mercedes
    Bilbao, Jose I.
    Rodriguez-Fraile, Macarena
    Rodriguez, Javier
    Benito, Alberto
    Dominguez, Ines
    D'Avola, Delia
    Herrero, Jose I.
    Quiroga, Jorge
    Prieto, Jesus
    Sangro, Bruno
    [J]. HEPATOLOGY, 2013, 57 (03) : 1078 - 1087
  • [7] Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma
    Kallini, Joseph Ralph
    Gabr, Ahmed
    Salem, Riad
    Lewandowski, Robert J.
    [J]. ADVANCES IN THERAPY, 2016, 33 (05) : 699 - 714
  • [8] Image-Guided Personalized Predictive Dosimetry by Artery-Specific SPECT/CT Partition Modeling for Safe and Effective 90Y Radioembolization
    Kao, Yung Hsiang
    Tan, Andrew Eik Hock
    Burgmans, Mark Christiaan
    Irani, Farah Gillian
    Khoo, Li Ser
    Lo, Richard Hoau Gong
    Tay, Kiang Hiong
    Tan, Bien Soo
    Chow, Pierce Kah Hoe
    Ng, David Chee Eng
    Goh, Anthony Soon Whatt
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2012, 53 (04) : 559 - 566
  • [9] Volume perfusion computed tomography (VPCT) based evaluation of response to TACE using two different sized drug eluting beads in patients with nonresectable hepatocellular carcinoma: Impact on tumor and liver parenchymal vascularisation
    Kaufmann, S.
    Horger, T.
    Oelker, A.
    Beck, S.
    Schulze, M.
    Nikolaou, K.
    Ketelsen, D.
    Horger, M.
    [J]. EUROPEAN JOURNAL OF RADIOLOGY, 2015, 84 (12) : 2548 - 2554
  • [10] Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: A consensus panel report from the Radioembolization Brachytherapy Oncology Consortium
    Kennedy, Andrew
    Nag, Subir
    Salem, Riad
    Murthy, Ravi
    McEwan, Alexander J.
    Nutting, Charles
    Benson, Al, III
    Espat, Joseph
    Bilbao, Jose Ignacio
    Sharma, Ricky A.
    Thomas, James P.
    Coldwell, Douglas
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 68 (01): : 13 - 23